Sculptor Capital LP Invests $426 Million in Sotera Health Company $SHC

Sculptor Capital LP purchased a new position in Sotera Health Company (NASDAQ:SHC) during the second quarter, Holdings Channel reports. The fund purchased 24,000,000 shares of the company’s stock, valued at approximately $426,000,000. Sotera Health makes up about 3.5% of Sculptor Capital LP’s holdings, making the stock its 3rd largest position. Sculptor Capital LP owned about 0.08% of Sotera Health as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in the stock. IFP Advisors Inc raised its position in Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares during the period. Rothschild Investment LLC purchased a new position in Sotera Health in the fourth quarter valued at about $27,000. Root Financial Partners LLC boosted its stake in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after acquiring an additional 1,455 shares during the last quarter. Meeder Asset Management Inc. bought a new position in shares of Sotera Health during the 2nd quarter valued at approximately $37,000. Finally, EverSource Wealth Advisors LLC grew its position in shares of Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after acquiring an additional 2,935 shares during the period. Institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Performance

Shares of SHC stock opened at $19.51 on Wednesday. The firm’s 50 day moving average is $17.89 and its 200 day moving average is $16.36. The stock has a market capitalization of $5.57 billion, a P/E ratio of 34.23 and a beta of 1.77. Sotera Health Company has a 12 month low of $13.09 and a 12 month high of $19.85. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The business had revenue of $321.38 million during the quarter, compared to analyst estimates of $309.70 million. During the same period in the previous year, the business earned $0.20 EPS. Sotera Health’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, sell-side analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 price target for the company. Citigroup upped their price objective on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a research note on Friday, August 7th. JPMorgan Chase & Co. increased their price objective on Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Barclays raised their target price on Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Finally, Weiss Ratings upgraded Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $21.50.

Insiders Place Their Bets

In related news, insider Michael P. Rutz sold 150,000 shares of the business’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the sale, the insider directly owned 334,279 shares in the company, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 1,294,515 shares of company stock valued at $23,999,528 over the last ninety days. Corporate insiders own 15.36% of the company’s stock.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.